Dermal infiltrate of enlarged macrophages in patients receiving chemotherapy

Journal of Cutaneous Pathology

Volumn 25, Issue 5, 1998, Pages 259-264

  Valks, Ruud ^a   Vargas, Erich ^a   Muñoz, Elia ^a   Fernández Herrera, Jesus ^a   Garcia Diéz, Amaro ^a   Fraga, Javier ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; BREAST CANCER; CELL DENSITY; CELL SIZE; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLINICAL ARTICLE; CYTOMEGALOVIRUS INFECTION; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MALE; NONHODGKIN LYMPHOMA; RASH; SKIN BIOPSY;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ERUPTIONS; EXANTHEMA; FEMALE; GRANULOCYTE COLONY-STIMULATING FACTOR; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; NEOPLASMS; SKIN;

EID: 0031801361     PISSN: 03036987     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0560.1998.tb01730.x     Document Type: Article

References (16)

1. Wakefield PE, James WD, Samlaska CP, Meltzer MS. Colony-stimulating factors. J Am Acad Dermatol 1990: 23: 903.
2. Johnson ML, Grimwood RE. Leukocyte colony-stimulating factors: a review of associated dermatoses and vasculitides. Arch Dermatol 1994: 130: 77.
3. Ross HJ, Moy LA, Kaplan R, Figlin RA. Bullous pyoderma gangrenosum after granulocyte colony-stimulating factor treatment. Cancer 1991: 68: 441.
4. Paydas S, Sahin B, Seyrek E, et al. Sweet's syndrome associated with G-CSF. Br J Haematol 1993: 85: 191.
5. Jain KK. Cutaneous vasculitis associated with granulocyte colony-stimulating factor. J Am Acad Dermatol 1994: 31: 213.
6. Ostlere LS, Harris D, Prentice HG, Rustin MHA. Widespread folliculitis induced by human granulocyte colony-stimulating factor therapy. Br J Dermatol 1992: 127: 193.
7. Mehregan DR, Fransway AF, Edmonson JH, Leiferman KM. Cutaneous reactions to granulocyte-monocyte colony-stimulating factor. Arch Dermatol 1992: 128: 1055.
8. Horn TD, Burke PJ, Karp JE, Hood AF. Intravenous administration of recombinant human granulocyte-macrophage colony-stimulating factor causes a cutaneous eruption. Arch Dermatol 1991: 127: 49.
9. Scott GA. Report of three cases of cutaneous reactions to granulocyte-macrophage colony-stimulating factor and a review of the literature. Am J Dermatopathol 1995: 17: 107.
10. Glass LF, Fotopoulos T, Messina JL. A generalized cutaneous reaction induced by granulocyte colony-stimulating factor. J Am Acad Dermatol 1996: 34: 455.
11. Horn T, Lehmkuhle MA, Gore S, Hood A, Burke P. Systemic cytokine adminitration alters the histology of the eruption of lymphocyte recovery. J Cutan Pathol 1996: 23: 242.
12. Santa Cruz DJ, Samuels LE, Bauer EA, Phillips GL, Herzig GP. Epidermal dystrophy: clinicopathologic study of chemotherapeutic agent toxicity in ten patients. Lab Invest 1982: 46: 72.
13. Bhawan J, Malhotra R. Syringosquamous metaplasia, a distinctive eruption in patients receiving chemotherapy. Am J Dermatopathol 1990: 12: 1.
14. Rongioletti F, Ballestrero A, Bogliolo F, A Rebora. Necrotizing eccrine squamous syringometaplasia presenting as acral erythema. J Cutan Pathol 1991: 18: 453.
15. Valks R, Fraga J, Porras-Luque J, Figuera A, García-Díez A, Fernández-Herrera J. Chemotherapy-induced eccrine squamous syringometaplasia: a distinctive eruption in patients receiving hematopoietic progenitor cells. Arch Dermatol 1997: 133: 873.
16. Lerner TH, Barr RJ, Dolezal JF, Stagnone JJ. Syringomatous hyperplasia and eccrine squamous syringometaplasia associated with benoxaprofen therapy. Arch Dermatol 1987: 123: 1202.